All In Biotech

Drug Trial Radar · NCT00273338

DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])

A Phase 3, Randomized, Open-Label Study Evaluating DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (ASCENT-2)

Last checked: Nov 20, 2026Latest source record: Nov 6, 2007 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. Randomized with 1,200 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

1,200

Planned (sponsor's estimate)

Start

Jan 2006

Primary completion

Not stated

Study completion Nov 2007

Sponsor

Lead sponsor
NovaceaIndustry
Sponsor type
Industry
First posted
Jan 9, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is: * To evaluate the effect of DN-101 in combination with docetaxel (ASCENT regimen) on survival in metastatic androgen-independent prostate cancer The secondary objectives of this study are: * To determine the effect of the ASCENT regimen on the rate of thromboembolic events (blood clots) * To determine the effect of the ASCENT regimen on prevention of skeletal-related events (fractures) * A Separate sub-study will be conducted at selected study sites in North America to determine the population PK of DN-101.

Conditions

  • Prostate Cancer

Interventions

  • calcitriolDrug

  • docetaxelDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

222 sites in 9 countries. Site status is shown where the registry gives one.

  • Birmingham Hematology & Oncology Associates, LLC

    Birmingham, Alabama

  • Northwest Alabama Cancer Center

    Muscle Shoals, Alabama

  • Alaska Clinical Research Center

    Anchorage, Alaska

  • Hematology Associates - AOA

    Phoenix, Arizona

  • Premiere Oncology of Arizona

    Scottsdale, Arizona

  • Northern Arizona Hematology & Oncology Associates, AOA

    Sedona, Arizona

  • Southern Arizona VA Healthcare System

    Tucson, Arizona

  • U of Arizona / Arizona Cancer Center

    Tucson, Arizona

  • Genesis Cancer Center

    Hot Springs, Arkansas

  • Tower Cancer Research Foundation

    Beverly Hills, California

  • Pacific Shores Medical Group

    Long Beach, California

  • The Angeles Clinic and Research Institute, Inc.

    Los Angeles, California

  • UCLA department of Urology

    Los Angeles, California

  • Veterans Affairs Northern California Health Care System

    Martinez, California

  • Sutter Gould Medical Foundation

    Modesto, California

  • Monterey Bay Oncology

    Monterey, California

  • Comprehensive Cancer Center at

    Palm Springs, California

  • Sutter Cancer Center

    Sacramento, California

  • UCD Cancer Center-Clinical Trials

    Sacramento, California

  • Sharp Memorial Hospital

    San Diego, California

  • California Pacific Medical Center

    San Francisco, California

  • Stanford University

    Stanford, California

  • Rocky Mountain Cancer Centers

    Colorado Springs, Colorado

  • Georgetown University Lombardi Cancer Center

    Washington D.C., District of Columbia

  • Pasco Hernando Oncology Associates, P.A.

    14529 Cortez Blvd., Florida

  • North Broward Medical Center

    Deerfield Beach, Florida

  • Broward Oncology Associates

    Fort Lauderdale, Florida

  • Michael and Dianne Bienes Comprehensive Cancer Center

    Fort Lauderdale, Florida

  • Florida Cancer Specialists

    Fort Myers, Florida

  • Gainesville Hematology Oncology Associates

    Gainesville, Florida

  • University of Florida Shands Cancer Center

    Gainesville, Florida

  • Integrated Community Oncology Network

    Jacksonville, Florida

  • Sylvester Comprehensive Cancer Center, U of Miami

    Miami, Florida

  • Pasco Hernando Oncology Associates P.A.

    New Port Richey, Florida

  • Florida Cancer Institute

    New Port Richey, Florida

  • Innovative Medical Research of South Florida Inc.

    North Miami Beach, Florida

  • Ocala Oncology Center

    Ocala, Florida

  • Cancer Centers of Florida, P.A.

    Ocoee, Florida

  • AYS Urology

    Trinity, Florida

  • Phoebe Cancer Center

    Albany, Georgia

Showing 40 of 222 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.